Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
M	O
Service:	O
MEDICINE	O
Allergies:	O
Imdur	O
/	O
___	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Orthopnea,	O
leg	O
pain	O
and	O
swelling	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
Mr.	O
___	O
is	O
a	O
___	O
year	O
old	O
gentleman	O
with	O
history	O
of	O
CAD	O
s/p	O
stent	O
to	O
LAD	O
and	O
LCx	O
x2	O
in	O
___,	O
HTN,	O
HLD,	O
DM,	O
CKD,	O
AF	O
on	O
apixaban,	O
presenting	O
with	O
several	O
days	O
of	O
worsening	O
BLE	O
swelling,	O
orthopnea,	O
and	O
weight	O
gain.	O
Over	O
the	O
past	O
several	O
weeks,	O
he	O
has	O
been	O
fluid	O
overloaded,	O
which	O
was	O
being	O
managed	O
as	O
an	O
outpatient	O
by	O
Dr.	O
___	O
in	O
nephrology.	O
He	O
was	O
started	O
on	O
torsemide,	O
uptitrated	O
from	O
5	O
->	O
10	O
->	O
20mg.	O
His	O
weight	O
was	O
initially	O
222	O
lbs	O
several	O
weeks	O
ago,	O
and	O
improved	O
to	O
207	O
lbs.	O
However,	O
over	O
the	O
past	O
two	O
days,	O
his	O
weight	O
increased	O
to	O
209	O
lbs.	O
Additionally,	O
he	O
has	O
had	O
worsening	O
pain	O
in	O
his	O
LLE	O
for	O
the	O
past	O
1.5	O
weeks,	O
to	O
the	O
point	O
where	O
he	O
was	O
being	O
woken	O
up	O
by	O
the	O
pain	O
and	O
had	O
to	O
cut	O
his	O
dressings.	O
After	O
cutting	O
open	O
his	O
dressings,	O
he	O
found	O
the	O
LLE	O
was	O
erythematous	O
compared	O
to	O
the	O
RLE.	O
Additionally,	O
over	O
the	O
past	O
1.5	O
months,	O
he	O
has	O
been	O
having	O
progressively	O
worsening	O
dyspnea	O
on	O
exertion,	O
orthopnea,	O
and	O
PND	O
requiring	O
him	O
to	O
sleep	O
upright.	O
He	O
denies	O
and	O
chest	O
pain/pressure,	O
cough,	O
URI	O
symptoms,	O
fevers,	O
chills,	O
palpitations,	O
lightheadedness,	O
n/v/d,	O
or	O
urinary	O
symptoms.	O
Per	O
his	O
daughter,	O
he	O
likely	O
has	O
had	O
some	O
dietary	O
indiscretion	O
over	O
the	O
past	O
two	O
days,	O
with	O
higher	O
amounts	O
of	O
sodium	O
intake.	O
In	O
the	O
ED,	O
he	O
was	O
afebrile,	O
mildly	O
hypetensive	O
to	O
140/45,	O
with	O
a	O
HR	O
of	O
55	O
and	O
satting	O
99%	O
on	O
room	O
air.	O
His	O
exam	O
was	O
notable	O
for	O
JVD	O
and	O
___	O
wounds	O
and	O
blister,	O
some	O
ruptured,	O
with	O
warmth	O
of	O
the	O
LLE	O
anteriorly.	O
His	O
exam	O
was	O
concerning	O
for	O
nec	O
fasc,	O
and	O
he	O
had	O
a	O
CT	O
of	O
the	O
lower	O
extremities	O
revealing	O
diffuse	O
subcutaneous	O
edema,	O
areas	O
of	O
skin	O
thickening	O
and	O
ulceration,	B-Pressure_injury
and	O
no	O
underlying	O
drainable	O
fluid	O
collection	O
or	O
soft	O
tissue	O
gas.	O
Surgery	O
was	O
consulted	O
and	O
felt	O
that	O
presentation	O
was	O
not	O
consistent	O
with	O
nec	O
fasc,	O
but	O
was	O
more	O
consistent	O
with	O
bilateral	O
___	O
edema	O
with	O
weeping	O
ulcerated	O
bullae	O
consistent	O
with	O
venous	O
stasis,	O
and	O
recommended	O
admission	O
for	O
diuresis.	O
The	O
patient's	O
labs	O
were	O
notable	O
for	O
BNP	O
of	O
8499,	O
Cr	O
elevated	O
to	O
3.3	O
from	O
2.8	O
in	O
___,	O
and	O
stable	O
anemia.	O
CXR	O
revealed	O
mild	O
pulmonary	O
edema.	O
EKG	O
revealed	O
atrial	O
fibrillation	O
with	O
slow	O
response	O
at	O
55bpm,	O
IVCD,	O
and	O
sub-mm	O
ST	O
depressions	O
in	O
II	O
and	O
V4-V6.	O
He	O
was	O
given	O
clindamycin.	O
Upon	O
arrival	O
to	O
the	O
cardiology	O
floor,	O
he	O
reports	O
the	O
history	O
above.	O
He	O
continues	O
to	O
have	O
orthopnea,	O
and	O
denies	O
any	O
chest	O
pressure.	O
He	O
is	O
otherwise	O
comfortable.	O
He	O
reports	O
taking	O
his	O
torsemide	O
20mg	O
at	O
5pm,	O
and	O
has	O
had	O
increased	O
urinary	O
output	O
from	O
this.	O
Past	O
Medical	O
History:	O
-	O
Ischemic	O
HFpEF	O
-	O
CAD	O
s/p	O
stent	O
___	O
(and	O
___	O
per	O
outpatient	O
cardiology	O
note):	O
LAD	O
and	O
LCx	O
x2	O
-	O
Atrial	O
fibrillation	O
(onset	O
___	O
-	O
Skin	O
grafts	O
___	O
-	O
Diabetes	O
-	O
Hypertension	O
-	O
Dyslipidemia	O
-	O
CKD	O
-	O
Obesity	O
-	O
Venous	O
insufficency	O
-	O
Nephrolithiasis	O
-	O
Spinal	O
stenosis	O
L4-L5	O
-	O
Cervical	O
radiculopathy	O
-	O
E	O
coli	O
UTI	B-Urinary_tract_infection
___	O
-	O
BPH	O
-	O
Anemia	O
-	O
radial	O
ulnar	O
fracture	O
___	O
-	O
L	O
ankle	O
fracture	O
s/p	O
ORIF	O
___	O
-	O
Leg	B-Pressure_injury
ulcer	B-Pressure_injury
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
and	O
mother	O
-	O
heart	O
disease,	O
unspecified	O
Sister	O
-	O
lung	O
cancer	O
Physical	O
Exam:	O
ADMISSION	O
PHYSICAL	O
EXAM	O
======================	O
VS:	O
97.6,	O
BP-135/67,	O
HR-55,	O
RR-16,	O
O2-99	O
RA	O
GENERAL:	O
No	O
distress,	O
well	O
appearing	O
HEENT:	O
AT/NC,	O
anicteric	O
sclera,	O
MMM	O
NECK:	O
JVP	O
elevated	O
to	O
___	O
neck	O
at	O
45	O
degrees	O
(12)	O
CV:	O
irregular	O
rhythm,	O
bradycardic,	O
S1/S2,	O
no	O
murmurs,	O
gallops,	O
or	O
rubs	O
PULM:	O
mild	O
bibasilar	O
crackles	O
GI:	O
abdomen	O
soft,	O
nondistended,	O
nontender	O
in	O
all	O
quadrants,	O
no	O
rebound/guarding,	O
no	O
hepatosplenomegaly	O
EXTREMITIES:	O
LLE	O
with	O
erythema	O
and	O
warmth,	O
bilateral	O
pitting	O
edema	O
to	O
the	O
knees	O
with	O
multiple	O
bullae,	O
both	O
feet	O
are	O
cold,	O
but	O
with	O
peripheral	O
pulses	O
in	O
tact	O
PULSES:	O
1+	O
radial	O
pulses	O
bilaterally	O
NEURO:	O
Alert,	O
moving	O
all	O
4	O
extremities	O
with	O
purpose,	O
face	O
symmetric	O
DISCHARGE	O
PHYSICAL	O
EXAM	O
======================	O
VS:	O
98.6F,	O
100/48,	O
HR	O
64,	O
RR	O
18,	O
O2	O
99%	O
on	O
RA	O
General:	O
WDWN	B-Malnutrition
elderly	O
male,	O
pleasant,	O
NAD.	O
HEENT:	O
MMM,	O
nonicteric	O
sclera.	O
EOMI.	O
Neck:	O
JVP	O
not	O
elevated	O
Lungs:	O
Faint	O
bibasilar	O
crackles.	O
No	O
wheezing,	O
rhonchi.	O
No	O
coughing.	O
Normal	O
WOB	O
on	O
RA.	O
CV:	O
Irregular,	O
normal	O
S1,	O
S2.	O
No	O
murmur,	O
rubs,	O
or	O
gallop	O
appreciated.	O
Abdomen:	O
Soft,	O
ND.	O
NT	O
to	O
palpation.	O
Ext:	O
Warm,	O
well	O
perfused.	O
Legs	O
wrapped	O
in	O
bandages	O
due	O
to	O
bleeding	O
ulcers.	O
LLE	O
dressing	O
is	O
c/d/i.	O
Trace	O
pitting	O
edema	O
around	O
ankles	O
bilaterally.	O
Pertinent	O
Results:	O
==================	O
ADMISSION	O
LABS	O
==================	O
___	O
08:51PM	O
BLOOD	O
WBC-6.5	O
RBC-3.36*	O
Hgb-10.3*	O
Hct-33.6*	O
MCV-100*	O
MCH-30.7	O
MCHC-30.7*	O
RDW-13.8	O
RDWSD-50.3*	O
Plt	O
___	O
___	O
07:25AM	O
BLOOD	O
___	O
PTT-32.8	O
___	O
___	O
08:51PM	O
BLOOD	O
Glucose-130*	O
UreaN-74*	O
Creat-3.3*	O
Na-146	O
K-4.0	O
Cl-105	O
HCO3-26	O
AnGap-15	O
___	O
08:51PM	O
BLOOD	O
CK-MB-3	O
cTropnT-0.04*	O
proBNP-84___*	O
___	O
08:51PM	O
BLOOD	O
Calcium-9.2	O
Phos-4.8*	O
Mg-2.4	O
======================	O
PERTINENT	O
INTERIM	O
LABS	O
======================	O
___	O
04:45PM	O
BLOOD	O
LD(LDH)-214	O
TotBili-0.4	O
DirBili-<0.2	O
IndBili-0.4	O
___	O
04:45PM	O
BLOOD	O
calTIBC-243*	O
___	O
Folate-7	O
___	O
Ferritn-523*	O
TRF-187*	O
___	O
07:30AM	O
BLOOD	O
%HbA1c-7.4*	O
eAG-166*	O
===========	O
IMAGING	O
===========	O
___	O
CXR	O
FINDINGS:	O
There	O
is	O
mild	O
enlargement	O
of	O
the	O
cardiac	O
silhouette	O
with	O
pulmonary	O
vascular	O
congestion	O
evidence	O
of	O
mild	O
pulmonary	O
edema.	O
There	O
is	O
left	O
lung	O
base	O
retrocardiac	O
atelectasis.	O
Trace	O
right	O
pleural	O
effusion.	O
No	O
pneumothorax.	O
No	O
acute	O
osseous	O
abnormality.	O
TTE	O
___	O
The	O
left	O
atrial	O
volume	O
index	O
is	O
moderately	O
increased.	O
The	O
right	O
atrium	O
is	O
moderately	O
enlarged.	O
The	O
estimated	O
right	O
atrial	O
pressure	O
is	O
>15mmHg.	O
Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	O
depressed	O
secondary	O
to	O
focal	O
inferobasal	O
and	O
posterobasal	O
hypokinesis.	O
The	O
visually	O
estimated	O
left	O
ventricular	O
ejection	O
fraction	O
is	O
45%.	O
Moderately	O
dilated	O
right	O
ventricular	O
cavity	O
with	O
depressed	O
free	O
wall	O
motion.	O
Intrinsic	O
right	O
ventricular	O
systolic	O
function	O
is	O
likely	O
lower	O
due	O
to	O
the	O
severity	O
of	O
tricuspid	O
regurgitation.	O
The	O
aortic	O
sinus	O
is	O
mildly	O
dilated	O
with	O
normal	O
ascending	O
aorta	O
diameter	O
for	O
gender.	O
The	O
aortic	O
arch	O
diameter	O
is	O
normal.	O
The	O
aortic	O
valve	O
leaflets	O
(?#)	O
are	O
mildly	O
thickened.	O
There	O
is	O
no	O
aortic	O
valve	O
stenosis.	O
There	O
is	O
mild	O
[1+]	O
aortic	O
regurgitation.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	O
thickened	O
with	O
mild	O
bileaflet	O
systolic	O
prolapse.	O
There	O
is	O
trivial	O
mitral	O
regurgitation.	O
The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	O
thickened.	O
There	O
is	O
SEVERE	O
[4+]	O
tricuspid	O
regurgitation.	O
There	O
is	O
moderate	O
to	O
severe	O
pulmonary	O
artery	O
systolic	O
hypertension.	O
In	O
the	O
setting	O
of	O
at	O
least	O
moderate	O
to	O
severe	O
tricuspid	O
regurgitation,	O
the	O
pulmonary	O
artery	O
systolic	O
pressure	O
may	O
be	O
UNDERestimated.	O
Venous	O
Duplex	O
Reflux	O
(___):	O
Reflux	O
is	O
seen	O
within	O
the	O
right	O
popliteal	O
vein	O
and	O
peripheral	O
left	O
great	O
saphenous	O
vein.	O
ABIs/PVRs	O
(___):	O
No	O
evidence	O
of	O
arterial	O
insufficiency	O
to	O
the	O
lower	O
extremities	O
bilaterally.	O
Venous	O
Dup	O
U/S	O
(___):	O
The	O
right	O
great	O
and	O
bilateral	O
small	O
saphenous	O
veins	O
are	O
patent.	O
Renal	O
U/S	O
(___):	O
1.	O
No	O
hydronephrosis.	O
Thin	O
renal	O
cortex	O
bilaterally	O
consistent	O
with	O
chronic	O
renal	O
disease.	O
2.	O
Extremely	O
limited	O
Doppler	O
evaluation	O
of	O
the	O
kidneys	O
as	O
the	O
patient	O
is	O
unable	O
to	O
hold	O
his	O
breath.	O
Only	O
minimal	O
flow	O
could	O
be	O
identified	O
bilaterally	O
and	O
consequently	O
sonographic	O
evaluation	O
for	O
renal	O
artery	O
stenosis	O
cannot	O
be	O
obtained	O
for	O
this	O
patient.	O
CT	O
Abd/Pelvis	O
(___):	O
1.	O
No	O
retroperitoneal	O
hematoma	O
identified.	O
2.	O
Patchy	O
right	O
middle	O
lobe	O
airspace	O
disease	O
suggestive	O
of	O
developing	O
infectious	O
or	O
inflammatory	O
pneumonitis.	O
Correlate	O
with	O
respiratory	O
symptoms.	O
3.	O
Pulmonary	O
fibrosis	O
in	O
a	O
pattern	O
suggestive	O
of	O
UIP.	O
Correlate	O
with	O
patient's	O
clinical	O
history.	O
4.	O
Small	O
right	O
pleural	O
effusion,	O
trace	O
left	O
pleural	O
effusion	O
and	O
body	O
wall	O
edema	O
compatible	O
with	O
third	O
spacing.	O
5.	O
Multiple	O
well-circumscribed	O
low	O
attenuating	O
masses	O
within	O
the	O
pancreas	O
likely	O
represent	O
IPMNs	O
or	O
dilated	O
side-branches.	O
Recommend	O
12	O
month	O
follow-up	O
MRI	O
or	O
CT	O
to	O
ensure	O
stability.	O
RECOMMENDATION(S):	O
12	O
month	O
MRI	O
or	O
CT	O
of	O
the	O
abdomen	O
with	O
contrast	O
for	O
evaluation	O
of	O
the	O
pancreatic	O
lesions	O
as	O
above.	O
Renal	O
US	O
___	O
IMPRESSION:	O
1.	O
No	O
hydronephrosis.	O
Thin	O
renal	O
cortex	O
bilaterally	O
consistent	O
with	O
chronic	O
renal	O
disease.	O
2.	O
Extremely	O
limited	O
Doppler	O
evaluation	O
of	O
the	O
kidneys	O
as	O
the	O
patient	O
is	O
unable	O
to	O
hold	O
his	O
breath.	O
Only	O
minimal	O
flow	O
could	O
be	O
identified	O
bilaterally	O
and	O
consequently	O
sonographic	O
evaluation	O
for	O
renal	O
artery	O
stenosis	O
cannot	O
be	O
obtained	O
for	O
this	O
patient.	O
=============	O
MICROBIOLOGY	O
=============	O
==============	O
DISCHARGE	O
LABS	O
==============	O
___	O
06:14AM	O
BLOOD	O
WBC-6.9	O
RBC-2.57*	O
Hgb-7.9*	O
Hct-25.0*	O
MCV-97	O
MCH-30.7	O
MCHC-31.6*	O
RDW-14.6	O
RDWSD-50.9*	O
Plt	O
___	O
___	O
06:14AM	O
BLOOD	O
Plt	O
___	O
___	O
06:14AM	O
BLOOD	O
Glucose-127*	O
UreaN-102*	O
Creat-3.2*	O
Na-145	O
K-4.3	O
Cl-100	O
HCO3-26	O
AnGap-19*	O
___	O
06:14AM	O
BLOOD	O
Calcium-8.8	O
Phos-4.9*	O
Mg-2.3	O
Brief	O
Hospital	O
Course:	O
==========	O
SUMMARY	O
==========	O
Mr.	O
___	O
is	O
a	O
___	O
year	O
old	O
gentleman	O
with	O
history	O
of	O
CAD	O
s/p	O
stent	O
to	O
LAD	O
and	O
LCx	O
x2	O
in	O
___,	O
HTN,	O
HLD,	O
DM,	O
CKD,	O
AF	O
on	O
apixaban,	O
presenting	O
with	O
several	O
days	O
of	O
worsening	O
BLE	O
swelling	O
and	O
pain,	O
orthopnea,	O
and	O
weight	O
gain,	O
found	O
to	O
have	O
___	O
on	O
CKD,	O
admitted	O
to	O
___	O
for	O
HF	O
management	O
control	O
of	O
his	O
leg	O
bleeding.	O
===================	O
TRANSITIONAL	O
ISSUES	O
===================	O
[]	O
Please	O
follow	O
up	O
on	O
the	O
following	O
incidental	O
findings,	O
discovered	O
on	O
CT	O
A/P	O
on	O
___:	O
-->	O
Pulmonary	O
fibrosis	O
in	O
a	O
pattern	O
suggestive	O
of	O
UIP.	O
Correlate	O
with	O
patient's	O
clinical	O
history.	O
-->	O
Multiple	O
well-circumscribed	O
low	O
attenuating	O
masses	O
within	O
the	O
pancreas	O
likely	O
represent	O
IPMNs	O
or	O
dilated	O
side-branches.	O
Recommend	O
12	O
month	O
follow-up	O
MRI	O
or	O
CT	O
to	O
ensure	O
stability.	O
[]	O
Patient's	O
anticoagulation	O
for	O
atrial	O
fibrillation	O
was	O
stopped	O
due	O
to	O
leg	O
bleeding.	O
Please	O
consider	O
re-starting	O
anticoagulation	O
with	O
warfarin	O
when	O
his	O
legs	O
have	O
healed	O
[]	O
Please	O
see	O
extensive	O
wound	O
care	O
recommendations	O
in	O
Page	O
1	O
of	O
this	O
document	O
as	O
well	O
as	O
the	O
bottom	O
of	O
this	O
summary	O
[]	O
Arrangements	O
were	O
made	O
for	O
pt	O
to	O
see	O
vascular	O
medicine	O
specialist	O
for	O
extensive	O
___	O
edema	O
and	O
wounds	O
[]	O
Please	O
continue	O
to	O
work	O
up	O
this	O
pt's	O
anemia;	O
consider	O
GI	O
source.	O
DISCHARGE	O
WEIGHT:	O
90.1	O
kg	O
(198.63	O
lb)	O
DISCHARGE	O
CREATININE:	O
3.2	O
DISCHARGE	O
DIURESIS:	O
40	O
mg	O
torsemide	O
daily	O
CODE:	O
full	O
CONTACT:	O
___,	O
daughter,	O
Phone:	O
___	O
=============	O
ACUTE	O
ISSUES	O
=============	O
#	O
Acute	O
on	O
chronic	O
systolic	O
heart	O
failure	O
w/	O
mildly	O
reduced	O
EF:	O
Presenting	O
with	O
weight	O
gain	O
of	O
20lbs	O
in	O
outpatient	O
setting,	O
worsening	O
orthopnea,	O
dyspnea	O
on	O
exertion,	O
elevated	O
JVP,	O
BNP	O
of	O
8K,	O
and	O
pulmonary	O
edema	O
on	O
CXR.	O
Patient	O
had	O
been	O
uptitrated	O
on	O
home	O
torsemide	O
form	O
5mg	O
to	O
20mg	O
due	O
to	O
recent	O
weight	O
gain.	O
Potential	O
etiology	O
of	O
exacerbation	O
could	O
be	O
LLE	O
cellulitis	O
given	O
erythema	O
and	O
warmth	O
on	O
exam,	O
but	O
also	O
a	O
worsening	O
CKD	O
likely	O
a	O
major	O
contributor	O
as	O
he	O
required	O
high	O
dose	O
lasix	O
for	O
diuresis.	O
Also	O
has	O
regional	O
WMA	O
on	O
echo	O
so	O
new/recent	O
ischemia	O
is	O
possible,	O
but	O
less	O
likely	O
given	O
negative	O
troponin,	O
flat	O
MB,	O
and	O
no	O
recent	O
anginal	O
symptoms.	O
He	O
was	O
actively	O
and	O
effectively	O
diuresed	O
with	O
IV	O
lasix	O
120	O
mg	O
BID	O
with	O
improvement	O
in	O
orthopnea	O
and	O
lower	O
extremity	O
edema.	O
He	O
was	O
continued	O
on	O
home	O
metoprolol.	O
He	O
was	O
transitioned	O
to	O
oral	O
torsemide	O
40	O
mg	O
daily.	O
His	O
weight	O
on	O
discharge	O
was	O
90.1	O
kg	O
(198.63	O
lb).	O
#	O
___	O
on	O
CKD	O
vs	O
worsening	O
CKD	O
stage	O
IV	O
Followed	O
by	O
outpatient	O
nephrologist	O
Dr.	O
___	O
with	O
GFR	O
of	O
___	O
from	O
prior	O
___.	O
Likely	O
cardiorenal	O
given	O
evidence	O
of	O
volume	O
overload	O
on	O
exam	O
(discussed	O
above).	O
___	O
was	O
consulted	O
and	O
followed	O
the	O
patient	O
while	O
admitted.	O
They	O
agreed	O
with	O
aggressive	O
diuresis	O
and	O
goal	O
of	O
-2L	O
each	O
day.	O
Notably,	O
patient	O
responded	O
well	O
to	O
high	O
dose	O
IV	O
lasix.	O
On	O
admission,	O
the	O
patient	O
expressed	O
that	O
he	O
would	O
like	O
to	O
avoid	O
dialysis,	O
and	O
would	O
potentially	O
not	O
even	O
want	O
dialysis	O
if	O
it	O
was	O
life-threatening.	O
His	O
discharge	O
Cr	O
was	O
3.2.	O
#	O
Chronic	O
venous	O
stasis	O
ulcers	O
s/p	O
skin	O
grafting,	O
complicated	O
by	O
bleeding	O
#	O
Acute	O
blood	O
loss	O
anemia	O
on	O
chronic	O
anemia	O
Superficial	O
bilateral	O
lower	O
extremity	O
ulcerations	O
(L>R)	O
were	O
likely	O
worsened	O
acutely	O
in	O
the	O
setting	O
of	O
heart	O
failure	O
exacerbation	O
and	O
significant	O
lower	O
extremity	O
edema.	O
He	O
has	O
chronic	O
venous	O
stasis	O
ulcers,	O
s/p	O
grafting	O
in	O
the	O
past,	O
and	O
is	O
followed	O
by	O
wound	O
care	O
as	O
an	O
outpatient.	O
Concern	O
for	O
PAD	O
as	O
patient	O
has	O
risk	O
factors,	O
CAD,	O
and	O
pain	O
with	O
dangling	O
of	O
legs,	O
which	O
is	O
classic	O
signs	O
of	O
PAD;	O
however	O
ABIs	O
do	O
not	O
show	O
arterial	O
insufficiency.	O
Vascular	O
surgery	O
was	O
consulted	O
and	O
determined	O
there	O
was	O
no	O
need	O
for	O
surgical	O
intervention	O
as	O
vascular	O
studies	O
were	O
negative	O
for	O
occlusive	O
disease.	O
His	O
course	O
was	O
complicated	O
by	O
extensive	O
and	O
debilitating	O
bleeding	O
from	O
his	O
___	O
wounds,	O
requiring	O
pRBC	O
transfusions.	O
His	O
anticoagulation	O
was	O
ultimately	O
stopped	O
due	O
to	O
this	O
bleeding	O
after	O
conversation	O
with	O
this	O
pt	O
and	O
his	O
family.	O
He	O
may	O
restart	O
anticoagulation	O
once	O
his	O
legs	O
have	O
healed.	O
#	O
Presumed	O
Cellulitis	O
Patient	O
with	O
LLE	O
erythema,	O
warmth,	O
and	O
pain	O
concerning	O
for	O
cellulitis	O
but	O
no	O
leukocytosis	O
or	O
fevers.	O
Initially	O
on	O
Cefepime,	O
vanc,	O
flagyl	O
however,	O
de-escalated	O
due	O
to	O
lack	O
of	O
systemic	O
illness.	O
He	O
was	O
on	O
ampillicin-sulbactam	O
for	O
a	O
total	O
7	O
day	O
course	O
(___).	O
Vancomycin	O
was	O
discontinued	O
on	O
___	O
due	O
to	O
low	O
suspicion	O
for	O
MRSA.	O
#)	O
Atrial	O
fibrillation:	O
CHADS2VASC	O
of	O
5.	O
He	O
was	O
initially	O
continued	O
home	O
apixaban	O
2.5	O
mg	O
BID	O
for	O
anticoagulation,	O
but	O
this	O
was	O
discontinued	O
when	O
his	O
renal	O
function	O
worsened	O
slightly	O
due	O
to	O
concern	O
for	O
overanticoagulation.	O
He	O
was	O
transtitioned	O
to	O
heparin	O
gtt	O
and	O
eventually	O
to	O
warfarin,	O
but	O
he	O
was	O
unable	O
to	O
tolerate	O
any	O
anticoagulation	O
due	O
to	O
leg	O
bleeding	O
as	O
above.	O
He	O
should	O
re-evaluate	O
the	O
need	O
for	O
antocagulation	O
in	O
___	O
weeks	O
when	O
his	O
legs	O
have	O
healed	O
with	O
aggressive	O
wound	O
care.	O
Metoprolol	O
succinate	O
50	O
mg	O
daily	O
was	O
continued	O
for	O
rate	O
control.	O
==============	O
CHRONIC	O
ISSUES	O
==============	O
#	O
CAD	O
S/P	O
___	O
and	O
LCX	O
X2	O
w/	O
WMA	O
abnormality	O
on	O
echo:	O
Continued	O
home	O
metoprolol	O
50mg	O
daily,	O
aspirin	O
81mg	O
daily,	O
atorvastatin	O
40mg	O
daily	O
#	O
DM:	O
not	O
on	O
any	O
home	O
meds,	O
used	O
small	O
amount	O
of	O
sliding	O
scale	O
insulin.	O
A1c	O
was	O
7.5%,	O
within	O
goal	O
range	O
for	O
geriatric	O
patients.	O
#	O
HLD:	O
continued	O
atorvastatin	O
as	O
above	O
#	O
HTN:	O
as	O
above	O
==========================	O
WOUND	O
CARE	O
RECOMMENDATIONS	O
==========================	O
-When	O
patient	O
is	O
out	O
of	O
bed	O
he	O
needs	O
to	O
be	O
in	O
a	O
reclining	O
chair	O
with	O
his	O
legs	O
elevated	O
at	O
all	O
times	O
and	O
compression.	O
His	O
legs	O
should	O
be	O
elevated	O
on	O
two	O
pillows	O
when	O
in	O
bed.	O
-Continue	O
pressure	O
relief	O
measures	O
per	O
pressure	O
injury	O
guidelines.	O
-Support	O
nutrition/hydration.	O
-Gently	O
Wash	O
bilateral	O
lower	O
legs	O
with	O
moisturizing	O
foam	O
soap	O
and	O
warm	O
water	O
using	O
cotton	O
disposable	O
cloth	O
from	O
knees	O
to	O
toes.	O
-Gently	O
Dry	O
legs	O
with	O
Cotton	O
disposable	O
cloth.	O
-Wash	O
all	O
wounds	O
to	O
lower	O
legs	O
with	O
commercial	O
wound	O
cleaner	O
or	O
normal	O
saline.	O
-Gently	O
pat	O
dry	O
with	O
4X4	O
gauze	O
and	O
remove	O
any	O
sloughing	O
of	O
skin	O
from	O
unroofed	O
blisters.	O
-Apply	O
sooth	O
and	O
cool	O
ointment	O
to	O
bilateral	O
heels	O
and	O
intact	O
skin	O
of	O
lower	O
legs.	O
-Apply	O
blood	O
stop	O
to	O
actively	O
seeping	O
wounds.	O
-Apply	O
Xeroform	O
to	O
all	O
wound	O
beds.	O
-Cover	O
with	O
4X4	O
-Secure	O
with	O
kling	O
(	O
X	O
)Apply	O
Spiral	O
Ace	O
Wraps	O
to	O
B/L	O
___	O
(	O
X	O
)	O
2	O
ace	O
wraps	O
per	O
leg,	O
6	O
inch	O
and	O
ending	O
just	O
below	O
the	O
knees.	O
From	O
just	O
above	O
toes	O
to	O
just	O
below	O
knees	O
Before	O
patient	O
gets	O
OOB	O
or	O
after	O
elevating	O
___	O
for	O
___	O
minutes	O
prior	O
to	O
application.	O
-Remove	O
ace	O
wraps	O
at	O
bedtime	O
and	O
reapply	O
in	O
am.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Apixaban	O
2.5	O
mg	O
PO	O
BID	O
2.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
3.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
4.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
5.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
6.	O
Torsemide	O
20	O
mg	O
PO	O
DAILY	O
7.	O
Calcitriol	O
0.25	O
mcg	O
PO	O
4X/WEEK	O
(___)	O
8.	O
Calcitriol	O
0.5	O
mcg	O
PO	O
3X/WEEK	O
(___)	O
9.	O
Vitamin	O
E	O
400	O
UNIT	O
PO	O
DAILY	O
10.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Torsemide	O
40	O
mg	O
PO	O
DAILY	O
RX	O
*torsemide	O
20	O
mg	O
2	O
tablet(s)	O
by	O
mouth	O
daily	O
Disp	O
#*30	O
Tablet	O
Refills:*0	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
4.	O
Calcitriol	O
0.25	O
mcg	O
PO	O
4X/WEEK	O
(___)	O
5.	O
Calcitriol	O
0.5	O
mcg	O
PO	O
3X/WEEK	O
(___)	O
6.	O
Cyanocobalamin	O
1000	O
mcg	O
PO	O
DAILY	O
7.	O
Metoprolol	O
Succinate	O
XL	O
50	O
mg	O
PO	O
DAILY	O
8.	O
Nitroglycerin	O
SL	O
0.3	O
mg	O
SL	O
Q5MIN:PRN	O
chest	O
pain	O
9.	O
Vitamin	O
E	O
400	O
UNIT	O
PO	O
DAILY	O
10.Rolling	I-Mobile_with_aid
Walker	B-Mobile_with_aid
Rolling	B-Mobile_with_aid
walker	B-Mobile_with_aid
Dx:	O
___.33	O
Px:	O
good	O
___	O
13	O
mon	O
Discharge	O
Disposition:	O
Home	O
With	O
Service	B-Has_carers
Facility:	O
___	O
Discharge	O
Diagnosis:	O
PRIMARY	O
DIAGNOSES	O
Acute	O
on	O
chronic	O
diastolic	O
heart	O
failure	O
Chronic	O
venous	O
stasis	O
dermatitis	O
Acute	O
blood	O
loss	O
anemia	O
cellulitis	O
SECONDARY	O
DIAGNOSES	O
Chronic	O
Kidney	O
disease,	O
baseline	O
creatinine	O
3	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Mr	O
___,	O
It	O
was	O
a	O
pleasure	O
taking	O
care	O
of	O
you	O
at	O
___	O
___.	O
WHY	O
WAS	O
I	O
ADMITTED	O
TO	O
THE	O
HOSPITAL?	O
-	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
because	O
you	O
had	O
a	O
heart	O
failure	O
exacerbation	O
which	O
caused	O
your	O
legs	O
to	O
swell	O
and	O
for	O
fluid	O
to	O
back	O
up	O
into	O
your	O
lungs.	O
WHAT	O
HAPPENED	O
WHILE	O
I	O
WAS	O
IN	O
THE	O
HOSPITAL?	O
-	O
We	O
gave	O
you	O
medication	O
(Lasix)	O
through	O
the	O
IV	O
to	O
remove	O
the	O
fluid	O
from	O
your	O
lungs	O
-	O
Your	O
legs	O
were	O
bleeding,	O
so	O
we	O
asked	O
our	O
vascular	O
surgery	O
colleagues	O
to	O
evaluate	O
your	O
legs.	O
They	O
didn't	O
think	O
an	O
intervention	O
would	O
be	O
helpful	O
to	O
you.	O
-	O
We	O
talked	O
with	O
you	O
and	O
stopped	O
your	O
anticoagulation	O
(apixiban,	O
and	O
later	O
wafarin)	O
and	O
your	O
bleeding	O
significantly	O
improved.	O
WHAT	O
SHOULD	O
I	O
DO	O
WHEN	O
I	O
GO	O
HOME?	O
-	O
You	O
should	O
continue	O
to	O
take	O
your	O
medications	O
as	O
prescribed.	O
-	O
You	O
should	O
attend	O
the	O
appointments	O
listed	O
below.	O
-	O
Call	O
your	O
doctor	O
if	O
your	O
weight	O
goes	O
up	O
more	O
than	O
3	O
lbs.	O
-	O
We	O
think	O
that	O
you	O
should	O
not	O
take	O
any	O
anticoagulation	O
for	O
a	O
while	O
as	O
your	O
legs	O
heal.	O
You	O
can	O
talk	O
about	O
starting	O
this	O
again	O
with	O
your	O
doctor	O
in	O
the	O
future	O
when	O
your	O
legs	O
are	O
better.	O
We	O
wish	O
you	O
the	O
best!	O
Your	O
___	O
Care	O
Team	O
Followup	O
Instructions:	O
___	O

